Skip to main content

Peer Review reports

From: Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial

Original Submission
23 Nov 2016 Submitted Original manuscript
6 Dec 2016 Author responded Author comments - Kenya Kamimura
Resubmission - Version 2
6 Dec 2016 Submitted Manuscript version 2
23 Feb 2017 Author responded Author comments - Kenya Kamimura
6 Feb 2017 Reviewed Reviewer Report - Hideo Baba
20 Feb 2017 Reviewed Reviewer Report - Limin Wang
Resubmission - Version 3
23 Feb 2017 Submitted Manuscript version 3
1 Apr 2017 Author responded Author comments - Kenya Kamimura
Resubmission - Version 4
1 Apr 2017 Submitted Manuscript version 4
9 Apr 2017 Author responded Author comments - Kenya Kamimura
Resubmission - Version 5
9 Apr 2017 Submitted Manuscript version 5
27 Apr 2017 Author responded Author comments - Kenya Kamimura
Resubmission - Version 6
27 Apr 2017 Submitted Manuscript version 6
Publishing
3 May 2017 Editorially accepted
10 May 2017 Article published 10.1186/s12885-017-3320-7

You can find further information about peer review here.

Back to article page